CAD protein

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Neodop (talk | contribs) at 15:11, 16 November 2016. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

CAD
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesCAD, CDG1Z, carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase, GATD4, EIEE50, DEE50
External IDsOMIM: 114010; MGI: 1916969; HomoloGene: 1412; GeneCards: CAD; OMA:CAD - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001306079
NM_004341

NM_001289522
NM_001289523
NM_023525

RefSeq (protein)

NP_001293008
NP_004332

NP_001276451
NP_001276452
NP_076014
NP_001390328
NP_001390329

Location (UCSC)Chr 2: 27.22 – 27.24 MbChr 5: 31.21 – 31.24 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
Identifiers
SymbolCAD
NCBI gene790
HGNC1424
OMIM114010
RefSeqNM_004341
UniProtP27708
Other data
EC number2.1.3.2
LocusChr. 2 p21
Search for
StructuresSwiss-model
DomainsInterPro

CAD protein (carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase) is a trifunctional multi-domain enzyme involved in the first three steps of pyrimidine biosynthesis. De-novo synthesis starts with cytosolic carbamoylphosphate synthetase II which uses glutamine, carbon dioxide and ATP. This enzyme is inhibited by uridine triphosphate (feedback inhibition).

In 2015, the first observed pathological mutations of CAD were found in a four-year-old boy.[5]

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000084774Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000013629Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Ng, B. G.; Wolfe, L. A.; Ichikawa, M.; Markello, T.; He, M.; Tifft, C. J.; Gahl, W. A.; Freeze, H. H. (12 February 2015). "Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors". Human Molecular Genetics. 24 (11): 3050–3057. doi:10.1093/hmg/ddv057.

External links